Glenmark Pharmaceuticals has informed that it enclosed a Press Release issued by its wholly owned subsidiary company Glenmark Pharmaceuticals Inc., USA relating to entering into an agreement with U.S. Department of Justice, Antitrust Division (DOJ).
The above information is a part of company’s filings submitted to BSE.